Downstream Processing Market Strategy And Industry Forecasts Till, 2022 - 2030.
The global downstream processing market size was estimated at USD 26.6 billion in 2021. and is expected to expand at a compound annual growth rate (CAGR) of 15.0% from 2022 to 2030. A rise in the utilization of downstream processing techniques for the development of COVID-19 vaccines is a significant factor driving the market. In March 2022, Rentschler Biopharma and Vetter released the launch of Xpert Alliance, a collaborative representation of their strategic relationship. The visualization is intended to “bring to life” this continuing collaboration and highlight its successful operation in offering effective solutions to customers’ evolving and growing demands in the field of challenging biopharmaceuticals.
In April 2022, Bayer revealed that it is considering a collaboration wherein Ginkgo Bioworks will purchase Bayer’s West Sacramento Biologics R&D location as well as its internal discovery and lead optimization platform. The deal will allow Bayer to improve its leadership position in biologicals, gain access to critical supporting technologies in synthetic biology, and preserve Bayer’s position as the preferred biologics research, development, and commercial partner. In January 2021, Thermo Fisher Scientific announced that it supported 250 projects for COVID-19 therapy as well as vaccine production in 2020.
Gather more insights about the market drivers, restrains and growth of the Global Downstream Processing market
The company leverages its CDMO capabilities as well as its bioprocess consumables and equipment offerings for these projects. It has also partnered with Singapore and the U.S. government to expand its vaccine and therapy development capacities. Similar efforts have been made by EMD Millipore, Cytiva, Pall Biotech, and other companies to use their bioprocess offerings for COVID-19 therapeutics development. A rise in R&D activities pertaining to advanced bioprocess technologies has resulted in the adoption of continuous downstream processing systems for multicomponent separations, perfusion chromatography systems, high-throughput process development, and high-resolution membrane systems.
This has led to an increase in the need for improving bioprocessing technologies for addressing the purification bottleneck. The number of CMOs in the market for downstream processing has increased as outsourcing helps pharmaceutical manufacturers in reducing the high initial capital investments and procedure costs. CMOs help drug manufacturers in optimizing downstream purification, in addition to other processes, such as cell culture preparation, chromatography, mixing, concentration, process monitoring, and disposable technologies.
Browse through Grand View Research's Biotechnology Industry Research Reports.
Viral Vectors And Plasmid DNA Manufacturing Market - The global viral vectors and plasmid DNA manufacturing market size was valued at USD 2.87 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.71% from 2022 to 2030. Viral vectors are tools for delivering genetic material into cells.
Genotyping Market - The global genotyping market was valued at USD 12.65 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2022 to 2030. The growth can be attributed to technological advancements, the rising prevalence of cancer & genetic disorders, and increasing R&D funding for precision medicine research.
Downstream Processing Market Segmentation
Grand View Research has segmented the global downstream processing market based on product, technique, application, and region:
Downstream Processing Product Outlook (Revenue, USD Million, 2017 - 2030)
·
·
·
·
·
·
Downstream Processing Technique Outlook (Revenue, USD Million, 2018 - 2030)
·
·
·
·
·
Downstream Processing Application Outlook (Revenue, USD Million, 2018 - 2030)
·
·
·
·
·
Downstream Processing Regional Outlook (Revenue, USD Million, 2018 - 2030)
·
·
·
·
·
Market Share Insights
April 2022 - Merck entered a partnership with the administrative management Board at the Wuxi National High-Tech Industrial Development Zone. To considerably enlarge Merck’s premier Mobius a Single-Use production center in China.
February 2022 - Sartorius completed its purchase of Novasep’s chromatography section. The portfolio bought includes chromatography systems designed largely for smaller biomolecules like peptides, oligonucleotides, and insulin, as well as new technologies for biologics’ continuous production.
Key Companies profiled:
Some prominent players in the global Downstream Processing market include
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Comments
Post a Comment